BSE Live
Sep 29, 16:01Prev. Close
8819.10
Open Price
8819.15
Bid Price (Qty.)
8886.60 (2)
Offer Price (Qty.)
8886.60 (1)
NSE Live
Sep 29, 15:10Prev. Close
8811.50
Open Price
8812.00
Bid Price (Qty.)
8884.50 (3)
Offer Price (Qty.)
8904.00 (8)
Balance Sheet of AstraZeneca Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
Total Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | |
Reserves and Surplus | 765.35 | 706.92 | 583.69 | 506.39 | 451.17 | |
Total Reserves and Surplus | 765.35 | 706.92 | 583.69 | 506.39 | 451.17 | |
Total Shareholders Funds | 770.35 | 711.92 | 588.69 | 511.39 | 456.17 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 38.45 | 2.78 | 3.69 | 5.02 | 8.63 | |
Long Term Provisions | 6.32 | 6.21 | 8.56 | 7.50 | 6.41 | |
Total Non-Current Liabilities | 44.77 | 8.99 | 12.25 | 12.52 | 15.04 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 456.30 | 196.51 | 227.88 | 188.06 | 178.37 | |
Other Current Liabilities | 140.17 | 117.19 | 114.37 | 104.42 | 88.21 | |
Short Term Provisions | 106.53 | 43.42 | 41.68 | 40.17 | 36.92 | |
Total Current Liabilities | 703.00 | 357.12 | 383.93 | 332.65 | 303.50 | |
Total Capital And Liabilities | 1,518.12 | 1,078.03 | 984.87 | 856.56 | 774.71 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 63.58 | 64.57 | 68.86 | 74.49 | 80.96 | |
Intangible Assets | 0.66 | 2.11 | 0.00 | 0.00 | 0.00 | |
Capital Work-In-Progress | 0.00 | 0.27 | 1.33 | 2.20 | 4.02 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 64.24 | 66.95 | 70.19 | 76.69 | 84.98 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 41.56 | 21.25 | 20.67 | 16.30 | 14.53 | |
Long Term Loans And Advances | 0.11 | 0.27 | 0.88 | 0.41 | 4.33 | |
Other Non-Current Assets | 69.86 | 56.85 | 57.66 | 57.49 | 52.11 | |
Total Non-Current Assets | 175.77 | 145.32 | 149.40 | 150.89 | 155.95 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 548.50 | 227.88 | 190.21 | 140.22 | 159.80 | |
Trade Receivables | 184.88 | 153.13 | 107.52 | 85.89 | 85.19 | |
Cash And Cash Equivalents | 536.70 | 505.84 | 500.48 | 448.46 | 352.35 | |
Short Term Loans And Advances | 0.30 | 0.13 | 0.08 | 0.09 | 0.36 | |
OtherCurrentAssets | 71.97 | 45.73 | 37.18 | 31.01 | 21.06 | |
Total Current Assets | 1,342.35 | 932.71 | 835.47 | 705.67 | 618.76 | |
Total Assets | 1,518.12 | 1,078.03 | 984.87 | 856.56 | 774.71 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 98.51 | 138.25 | 132.28 | 124.60 | 89.17 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 6.40 | 6.10 | 374.70 | 255.20 | 238.20 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 104.90 | 109.40 | 61.20 | 44.20 | 31.77 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
31.07.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
07.04.2025
10.03.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y
13.08.2024
AstraZeneca Standalone June 2024 Net Sales at Rs 387.52 crore, up 31.16% Y-o-Y